Old Web
English
Sign In
Acemap
>
authorDetail
>
Leyre Zubiri Oteiza
Leyre Zubiri Oteiza
University of Navarra
Medicine
Pathology
Oncology
Internal medicine
Carboplatin
6
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Estudio sobre potenciales biomarcadores en pacientes con melanoma metastásico en tratamiento con inhibidores de BRAF
2016
Leyre Zubiri Oteiza
Show All
Source
Cite
Save
Citations (0)
Id1 and Id3 genes to confer poor prognosis in KRAS-mutant (KM) lung adenocarcinoma (LA) patients: Effect of gene silencing on metastatic rate to the liver and on survival.
2016
Journal of Clinical Oncology
Marta Román
Inés López
Leyre Zubiri Oteiza
Rodrigo Sanchez
Diego Salas
Itziar Gardeazabal
Iosune Baraibar
Marta Santisteban
Silvestre Vicent
Isabel Gil-Aldea
Maite Martínez Aguillo
Berta Hernandez
José María López-Picazo
Alfonso Gurpide
Jose Luis Perez-Gracia
Ignacio Gil Bazo
Show All
Source
Cite
Save
Citations (0)
Eribulin and carboplatin in heavily pretreated patients with metastatic breast cancer: A single institution experience.
2015
Journal of Clinical Oncology
Patricia Martin Romano
Iosune Baraibar
Oscar Fernández-Hidalgo
Marta Santisteban
Jaime Espinós
Diego Salas
Pablo Sala
Itziar Gardeazabal
Leyre Zubiri Oteiza
J. M. Aramendia
Show All
Source
Cite
Save
Citations (0)
1